|
US20040067532A1
(en)
|
2002-08-12 |
2004-04-08 |
Genetastix Corporation |
High throughput generation and affinity maturation of humanized antibody
|
|
WO2007085266A1
(en)
*
|
2006-01-30 |
2007-08-02 |
Dako Denmark A/S |
High-speed quantification of antigen specific t-cells in whole blood by flow cytometry
|
|
EP1878744A1
(en)
*
|
2006-07-13 |
2008-01-16 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them
|
|
US20080255004A1
(en)
*
|
2006-11-15 |
2008-10-16 |
Invitrogen Dynal As |
Methods of reversibly binding a biotin compound to a support
|
|
EP2155782A2
(en)
|
2007-03-26 |
2010-02-24 |
Dako Denmark A/S |
Mhc peptide complexes and uses thereof in infectious diseases
|
|
WO2009003493A2
(en)
|
2007-07-03 |
2009-01-08 |
Dako Denmark A/S |
Mhc multimers, methods for their generation, labeling and use
|
|
WO2009036379A2
(en)
|
2007-09-14 |
2009-03-19 |
Adimab, Inc. |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
US12529164B2
(en)
|
2007-09-14 |
2026-01-20 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
WO2009039854A2
(en)
|
2007-09-27 |
2009-04-02 |
Dako Denmark A/S |
Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
|
|
DK2254592T3
(da)
|
2008-02-28 |
2019-09-09 |
Dako Denmark As |
MHC-multimerer til Borrelia-diagnostik og sygdom
|
|
WO2010009735A2
(en)
|
2008-07-23 |
2010-01-28 |
Dako Denmark A/S |
Combinatorial analysis and repair
|
|
GB0817244D0
(en)
|
2008-09-20 |
2008-10-29 |
Univ Cardiff |
Use of a protein kinase inhibitor to detect immune cells, such as T cells
|
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
|
US11992518B2
(en)
|
2008-10-02 |
2024-05-28 |
Agilent Technologies, Inc. |
Molecular vaccines for infectious disease
|
|
JP5686098B2
(ja)
*
|
2009-09-17 |
2015-03-18 |
Jsr株式会社 |
アビジンとビオチン誘導体の解離方法及び解離剤
|
|
EP3144673B1
(en)
|
2010-05-06 |
2019-07-10 |
Adaptive Biotechnologies Corporation |
Monitoring lymphoid neoplasm status using clonotype profiles
|
|
US9345748B2
(en)
|
2010-09-21 |
2016-05-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-SSX-2 T cell receptors and related materials and methods of use
|
|
US10023657B2
(en)
|
2010-10-01 |
2018-07-17 |
Ludwig Institute For Cancer Research Ltd. |
Reversible protein multimers, methods for their production and use
|
|
ES2682750T5
(en)
|
2011-07-18 |
2025-02-04 |
Iba Lifesciences Gmbh |
Method of reversibly staining a target cell
|
|
WO2013056090A1
(en)
*
|
2011-10-12 |
2013-04-18 |
University Of Connecticut |
Affinity-based materials for the non-destructive separation and recovery of cells
|
|
SG11201404991YA
(en)
|
2012-02-23 |
2014-09-26 |
Stage Cell Therapeutics Gmbh |
Chromatographic isolation of cells and other complex biological materials
|
|
CN102662054B
(zh)
*
|
2012-05-10 |
2014-08-13 |
东南大学 |
一种同步检测特异性胸腺依赖性淋巴细胞数量和功能的方法
|
|
EP2920204B1
(en)
|
2012-11-16 |
2019-09-18 |
IBA GmbH |
Streptavidin muteins and methods of using them
|
|
NZ759969A
(en)
|
2013-12-20 |
2022-12-23 |
Fred Hutchinson Cancer Center |
Tagged chimeric effector molecules and receptors thereof
|
|
US9970849B2
(en)
|
2014-01-21 |
2018-05-15 |
Stemcell Technologies Inc. |
Method for separating target entities from a sample using a composition of mono-specific tetrameric antibody complexes coupled to a surface
|
|
RS62471B1
(sr)
|
2014-04-16 |
2021-11-30 |
Juno Therapeutics Gmbh |
Metode, kompleti i uređaji za proširenje populacije ćelija
|
|
IL292038B2
(en)
|
2014-04-23 |
2024-12-01 |
Juno Therapeutics Inc |
Methods for enriching or producing immune cell populations for adoptive therapy
|
|
CN106662584B
(zh)
|
2014-04-30 |
2020-05-05 |
Iba股份有限公司 |
分离靶细胞的方法
|
|
EP3037820A1
(en)
|
2014-12-27 |
2016-06-29 |
Miltenyi Biotec GmbH |
Cell detection methods and reagents having a releasable labelling moiety
|
|
WO2016166568A1
(en)
|
2015-04-16 |
2016-10-20 |
Juno Therapeutics Gmbh |
Methods, kits and apparatus for expanding a population of cells
|
|
EP3288570A4
(en)
|
2015-04-29 |
2018-11-21 |
Fred Hutchinson Cancer Research Center |
Modified stem cells and uses thereof
|
|
JP6657721B2
(ja)
|
2015-09-30 |
2020-03-04 |
ソニー株式会社 |
細胞の分析方法、細胞分析用チップ、細胞分析用試薬、細胞分析用キット及び細胞分析用装置
|
|
MA45489A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés de culture de cellules, kits et appareil associés
|
|
RU2761555C2
(ru)
|
2015-10-22 |
2021-12-09 |
Джуно Терапьютикс Гмбх |
Способы, наборы, средства и устройства для трансдукции
|
|
KR102908806B1
(ko)
*
|
2015-10-22 |
2026-01-07 |
주노 테라퓨틱스 게엠베하 |
세포의 배양 방법 및 이를 위한 키트와 장치
|
|
WO2017180420A1
(en)
|
2016-04-11 |
2017-10-19 |
Board Of Regents, The University Of Texas System |
Methods and compositions for detecting single t cell receptor affinity and sequence
|
|
WO2018001985A1
(en)
|
2016-06-28 |
2018-01-04 |
Technische Universitaet Muenchen |
Combination of reversible and irreversible cell labeling for analizing receptor-ligand koff rate
|
|
TW202332461A
(zh)
|
2016-08-11 |
2023-08-16 |
荷蘭商凱特製藥歐洲公司 |
製造和使用可溶性主要組織相容性複合體（ｍｈｃ）分子類之方法
|
|
US10294454B2
(en)
|
2016-08-24 |
2019-05-21 |
General Electric Company |
Methods and kits for cell activation
|
|
EP3336545A1
(en)
|
2016-12-13 |
2018-06-20 |
Miltenyi Biotec GmbH |
Reversible labeling of antigens in biological specimens
|
|
EP3336546B1
(en)
|
2016-12-13 |
2020-07-01 |
Miltenyi Biotec B.V. & Co. KG |
Reversible cell labelling with conjugates having two releasable binding sites
|
|
EP3571221A2
(en)
|
2017-01-20 |
2019-11-27 |
Juno Therapeutics GmbH |
Cell surface conjugates and related cell compositions and methods
|
|
AU2018260380B2
(en)
|
2017-04-27 |
2025-02-13 |
Juno Therapeutics Gmbh |
Oligomeric particle reagents and methods of use thereof
|
|
EP4549554A3
(en)
|
2017-07-29 |
2025-08-06 |
Juno Therapeutics, Inc. |
Reagents for expanding cells expressing recombinant receptors
|
|
EP3489684B1
(en)
|
2017-11-27 |
2024-06-26 |
Miltenyi Biotec B.V. & Co. KG |
Method for photobleaching stained cells
|
|
CN119193493A
(zh)
|
2017-12-08 |
2024-12-27 |
朱诺治疗学股份有限公司 |
生产工程化t细胞组合物的过程
|
|
CN116148467B
(zh)
*
|
2017-12-12 |
2026-05-26 |
清华大学 |
检测翻译后修饰蛋白质与其配体间相互作用的成套试剂
|
|
BR112021002390A2
(pt)
|
2018-08-09 |
2021-05-11 |
Juno Therapeutics Inc |
processos para gerar células modificadas e suas composições
|
|
US20210246189A1
(en)
|
2018-09-03 |
2021-08-12 |
Technische Universitaet Muenchen |
A double peptide tag combining reversibility and flexible functionalization
|
|
JP7504891B2
(ja)
|
2018-09-11 |
2024-06-24 |
ジュノー セラピューティクス インコーポレイテッド |
操作された細胞組成物のマススペクトロメトリー分析のための方法
|
|
WO2020089343A1
(en)
|
2018-10-31 |
2020-05-07 |
Juno Therapeutics Gmbh |
Methods for selection and stimulation of cells and apparatus for same
|
|
US20210393691A1
(en)
|
2018-11-06 |
2021-12-23 |
Juno Therapeutics, Inc. |
Process for producing genetically engineered t cells
|
|
WO2020127222A2
(en)
|
2018-12-17 |
2020-06-25 |
Immudex Aps |
Panel comprising borrelia mhc multimers
|
|
KR102922115B1
(ko)
|
2019-04-09 |
2026-02-04 |
누릭스 테라퓨틱스 인코포레이티드 |
Cbl-b 억제용의 3-치환된 피페리딘 화합물, 및 암 백신 및/또는 종양용해 바이러스와 조합된 cbl-b 억제제의 용도
|
|
US12436151B2
(en)
|
2019-04-12 |
2025-10-07 |
Miltenyi Biotec B.V. & Co. KG |
Conjugates having an enzymmatically releasable detection moiety and a barcode moiety
|
|
CA3140873A1
(en)
|
2019-05-17 |
2020-11-26 |
Nurix Therapeutics, Inc. |
Cyano cyclobutyl compounds for cbl-b inhibition and uses thereof
|
|
CN113966394A
(zh)
|
2019-05-28 |
2022-01-21 |
美天施生物科技有限两合公司 |
产生遗传修饰的t细胞的方法
|
|
US20220228101A1
(en)
|
2019-06-07 |
2022-07-21 |
Juno Therapeutics, Inc. |
Automated t cell culture
|
|
CA3294689A1
(en)
|
2019-06-26 |
2026-03-02 |
Nurix Therapeutics, Inc. |
Substituted benzyl-triazole compounds for cbl-b inhibition, and further uses thereof
|
|
US12653809B2
(en)
|
2019-07-30 |
2026-06-16 |
Nurix Therapeutics, Inc. |
Urea, amide, and substituted heteroaryl compounds for CBL-B inhibition
|
|
CN114600172A
(zh)
|
2019-08-30 |
2022-06-07 |
朱诺治疗学股份有限公司 |
用于将细胞分类的机器学习方法
|
|
WO2021047804A1
(en)
|
2019-09-11 |
2021-03-18 |
Miltenyi Biotec B.V. & Co. KG |
In vitro method for transduction of t cells in the presence of malignant cells
|
|
MX2022005145A
(es)
|
2019-10-30 |
2022-06-29 |
Juno Therapeutics Gmbh |
Dispositivos de estimulación y/o selección celular y método de uso.
|
|
WO2021122185A1
(en)
|
2019-12-20 |
2021-06-24 |
Miltenyi Biotec B.V. & Co. KG |
Reversible cell detection via mhc with conjugates having an enzymatically cleavable detection moiety
|
|
US20230090117A1
(en)
|
2020-01-28 |
2023-03-23 |
Juno Therapeutics, Inc. |
Methods for t cell transduction
|
|
AU2021213439B2
(en)
|
2020-01-31 |
2023-01-05 |
Cell.Copedia GmbH |
Methods of isolating a biological entity
|
|
CA3169672A1
(en)
|
2020-02-12 |
2021-08-19 |
Juno Therapeutics, Inc. |
Cd19-directed chimeric antigen receptor t cell compositions and methods and uses thereof
|
|
JP2023519099A
(ja)
|
2020-02-12 |
2023-05-10 |
ジュノー セラピューティクス インコーポレイテッド |
Ｂｃｍａ指向性キメラ抗原受容体ｔ細胞組成物ならびにその方法および使用
|
|
KR20230022868A
(ko)
|
2020-05-13 |
2023-02-16 |
주노 쎄러퓨티크스 인코퍼레이티드 |
재조합 수용체를 발현하는 공여자-배치 세포의 제조 방법
|
|
EP3916393B1
(en)
|
2020-05-27 |
2023-01-25 |
Miltenyi Biotec B.V. & Co. KG |
Method for detection of cells by repetitive staining and destaining
|
|
WO2022043023A1
(en)
|
2020-08-27 |
2022-03-03 |
Miltenyi Biotec B.V. & Co. KG |
Releasable reagents for cell separation
|
|
CN115997126B
(zh)
|
2020-09-07 |
2025-11-28 |
美天施生物科技有限两合公司 |
具有可酶促释放的检测部分和条形码部分的缀合物
|
|
CN117916256A
(zh)
|
2021-05-06 |
2024-04-19 |
朱诺治疗学有限公司 |
用于刺激和转导t细胞的方法
|
|
WO2023017115A1
(en)
|
2021-08-11 |
2023-02-16 |
Iba Lifesciences Gmbh |
Fractionation of cells based on a marker protein
|
|
EP4227423A1
(en)
|
2022-02-09 |
2023-08-16 |
Technische Universität München |
Means and methods for identifying high affinity t-cells
|
|
US20250297282A1
(en)
|
2022-05-05 |
2025-09-25 |
Juno Therapeutics Gmbh |
Viral-binding protein and related reagents, articles, and methods of use
|
|
WO2023230581A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Methods of manufacturing t cell therapies
|
|
WO2024100604A1
(en)
|
2022-11-09 |
2024-05-16 |
Juno Therapeutics Gmbh |
Methods for manufacturing engineered immune cells
|
|
CN121100267A
(zh)
|
2022-12-09 |
2025-12-09 |
朱诺治疗学股份有限公司 |
使用全息成像预测细胞表型的机器学习方法
|
|
US20260232729A1
(en)
|
2023-02-03 |
2026-08-13 |
C3S2 Gmbh |
Methods for non-viral manufacturing of engineered immune cells
|
|
WO2024182516A1
(en)
|
2023-02-28 |
2024-09-06 |
Juno Therapeutics, Inc. |
Cell therapy for treating systemic autoimmune diseases
|
|
EP4484441A1
(en)
|
2023-06-26 |
2025-01-01 |
Eberhard-Karls-Universität Tübingen |
Mhc-class i derived polypeptide
|
|
KR20260096851A
(ko)
|
2023-10-18 |
2026-06-24 |
티큐 테라퓨틱스 게엠베하 |
세포 치료제 제조 방법 및 관련 키트와 장치
|